Cathflo Activase
NDC 50242-041, Alteplase, injection, powder, lyophilized, for solution, from Genentech, Inc..
- Product NDC
- 50242-041
- Status
- Listed
- Labeler
- Genentech, Inc.
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA103172
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50242-041 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ALTEPLASE2.2 mg/2mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50242-041-10 | 50242004110 | 10 VIAL in 1 CARTON (50242-041-10) / 2 mL in 1 VIAL |
| 50242-041-64 | 50242004164 | 1 VIAL in 1 CARTON (50242-041-64) / 2 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/91ecdef2-95ff-42dd-a31c-c8a09cab3ad9Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=50242-041NADAC price for package 50242004164
GET /v1/drugs/nadac/50242004164
Use it
Look up 50242-041 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50242-041 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50242-041. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.